
The role of light in eye growth
IMI's new White Paper: Evidence from animal and human studies confirms outdoor time as a key strategy for delaying myopia onset.

IMI's new White Paper: Evidence from animal and human studies confirms outdoor time as a key strategy for delaying myopia onset.

The term ‘compassion fatigue’ is often applied as the personal cost of caring, but new research from the University of Auckland suggests the phenomenon could in fact be a self-fulfilling prophecy.

A new study associated virtual reality (VR) headset use with a reduced risk of dry eye in healthy patients, which authors said is due to elevated temperature inside the headset. While previous

Researchers at the UK’s Aston University will assess how screen use affects babies and their families during the first 1,001 days of life. The work, commissioned by the 1001 Critical Days Foundatio

Kim Down has joined the Ophthalmology New Zealand (ONZ) team as executive assistant, supporting CEO Moira McInerney.

A South Auckland pilot programme found community pharmacists, working with general practice nurses, significantly lowered and sustained blood glucose levels in patients with type 2 diabetes (T2D).

US researchers have launched a national clinical trial to test whether low-dose atropine eye drops can prevent the development of myopia in children.

With no frames in sight, new practice Illume Eye Care in Ponsonby, Auckland, is open for patients seeking anything from a comprehensive eye exam to specialised care in myopia management, contact lenses and speciality contact lenses, dry eye disease and ocular surface disease management, keratoconus

EssilorLuxottica boosted its myopia portfolio at the recent China International Import Expo in Shanghai, launching Essilor Stellest 2.0 in Greater China, with other key markets to follow in 2026.

University of Auckland medical student Robin Yang is the proud recipient of this year’s Gordon Sanderson Scholarship.

Research from Aspect’s Research Centre for Autism Practice (ARCAP) has identified significant barriers autistic people face when accessing eyecare in Australia and New Zealand.

Topcon Healthcare has signed a definitive agreement to acquire New Zealand-founded AI health-technology company Toku Eyes, now based in San Diego. The acquisition is part of the integration of Toku’s